Media headlines about Veeva Systems (NYSE:VEEV) have been trending somewhat positive on Friday, according to Accern Sentiment. The research group scores the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Veeva Systems earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave media stories about the technology company an impact score of 46.8474618643824 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:
- Medical Sector Gains Strength; Medidata Technicals Outflank Veeva (investors.com)
- What's in Store for Veeva Systems (VEEV) in Q1 Earnings? (finance.yahoo.com)
- What’s in Store for Veeva Systems (VEEV) in Q1 Earnings? (zacks.com)
- Lacework Helps Veeva Systems Automate Security and Compliance for its AWS Cloud (finance.yahoo.com)
- Veeva Systems Launches Veeva Nitro, Boosts MedTech Analytics (zacks.com)
A number of equities analysts have weighed in on VEEV shares. Canaccord Genuity upped their price objective on shares of Veeva Systems from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Stifel Nicolaus upped their price objective on shares of Veeva Systems from $67.00 to $70.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. DA Davidson started coverage on shares of Veeva Systems in a research report on Friday, February 2nd. They issued a “buy” rating and a $75.00 price objective for the company. ValuEngine raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Finally, Vetr cut shares of Veeva Systems from a “buy” rating to a “hold” rating and set a $61.05 price objective for the company. in a research report on Thursday, February 15th. Five equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $72.23.
Shares of Veeva Systems traded up $1.14, hitting $77.29, during trading hours on Friday, Marketbeat.com reports. 1,261,918 shares of the company were exchanged, compared to its average volume of 1,103,332. Veeva Systems has a one year low of $52.17 and a one year high of $79.15. The stock has a market capitalization of $10.84 billion, a price-to-earnings ratio of 84.01, a PEG ratio of 4.61 and a beta of 1.40.
Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Tuesday, February 27th. The technology company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.15 by $0.02. Veeva Systems had a net margin of 20.71% and a return on equity of 11.89%. The business had revenue of $184.92 million for the quarter, compared to analysts’ expectations of $180.13 million. equities research analysts expect that Veeva Systems will post 0.98 earnings per share for the current fiscal year.
In other Veeva Systems news, Director Paul J. Sekhri sold 4,622 shares of the firm’s stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $65.00, for a total value of $300,430.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Frederic Lequient sold 2,875 shares of the firm’s stock in a transaction dated Monday, March 5th. The stock was sold at an average price of $71.72, for a total transaction of $206,195.00. Following the completion of the transaction, the senior vice president now directly owns 2,875 shares in the company, valued at approximately $206,195. The disclosure for this sale can be found here. Insiders have sold 169,733 shares of company stock worth $12,965,920 in the last ninety days. Corporate insiders own 15.97% of the company’s stock.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, which allow pharmaceutical and biotechnology companies to target and support sales and marketing to physicians, other healthcare professionals, and healthcare organizations through various touch points, including in-person, email, and online; and Veeva Vault, a cloud-based enterprise content management platform and suite of applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.